Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03999632 · ClinicalTrials.gov registry record · NA
Effects of Wolffia Globosa (Mankai) in Patients Undergoing Bariatric Surgery.
A NA study of Bariatric Surgery Candidate and Diet Modification, sponsored by Cleveland Clinic Florida.
- Completed
- Registry status
- NA
- Development phase
- 3
- Enrollment target
- 1
- Study location
NCT03999632: Completed NA study of Bariatric Surgery Candidate and Diet Modification, sponsored by Cleveland Clinic Florida.
NCT03999632 is a NA study of Bariatric Surgery Candidate and Diet Modification that has completed, run by Cleveland Clinic Florida. The registered enrollment target is 3 participants, below the 113-participant average among 28 other Bariatric Surgery Candidate trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03999632, a NA study of Bariatric Surgery Candidate and Diet Modification, has completed, sponsored by Cleveland Clinic Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
- 1
- Study location
Study Summary
Candidates to bariatric surgery at The Bariatric and Metabolic Institute at Cleveland Clinic Florida are prescribed a high protein liquid diet for two weeks preoperatively and 2 weeks postoperatively. Whether Wolffia Globosa (Mankai), a plant based wholesome food, can serve as a natural alternative to liquid diet during the 2 week pre-operation and 2 weeks postoperation liquid based diet, is unknown. The investigators aim to address the effect of daily Wolffia Globosa (Mankai) administration on morbid/severely-obese patients during the 2 week pre-operative period and 2 weeks postoperatively as compared to iso protein-iso caloric shake source on the following parameters
Primary Outcome
QUALITY OF ALIMENTATION QUESTIONNAIRE is a questionnaire with 1 open ended question, 4 yes/no questions, and three 0-5 questions with 5 being the highest level
Conditions Studied
Interventions
- OTHER Dietary modification with introduction of Mankai
Study Locations (1)
Florida
- Cleveland Clinic Florida - Weston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2019-08-01 |
| Est. Completion | 2020-12-01 |
| Phase | NA |
What the finished NCT03999632 record still lists
NCT03999632 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 113-participant average among 28 other Bariatric Surgery Candidate trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Bariatric Surgery Candidate appearing as the primary indexed condition, and to 1 intervention - of which Dietary modification with introduction of Mankai is the first listed.
NCT03999632 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03999632 about?
NCT03999632 is a clinical study titled "Effects of Wolffia Globosa (Mankai) in Patients Undergoing Bariatric Surgery.". Candidates to bariatric surgery at The Bariatric and Metabolic Institute at Cleveland Clinic Florida are prescribed a high protein liquid diet for two weeks preoperatively and 2 weeks postoperatively. Whether Wolffia Globosa (Mankai), a plant based wholesome food, can serve as a natural alternative ...
What is the current status of trial NCT03999632?
This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2019-08-01. Estimated completion is 2020-12-01.
What conditions does trial NCT03999632 study?
This clinical trial studies the following conditions: Bariatric Surgery Candidate, Diet Modification.
What interventions are being tested in trial NCT03999632?
The interventions under investigation include: Dietary modification with introduction of Mankai (OTHER).
Who is sponsoring clinical trial NCT03999632?
This trial is sponsored by Cleveland Clinic Florida, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03999632 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bariatric Surgery Candidate
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03999632's enrollment target sits among peer trials
3 29th of 28 the lowest of 28 other Bariatric Surgery Candidate trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bariatric Surgery Candidate trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gut Microbiome and Sex as Risk Factors for Kidney Stones After Bariatric Surgery
RECRUITING · NA
-
GI Oxalate Absorption
RECRUITING · NA
-
Effects of Assisted Robotic vs Laparoscopic Sleeve Gastrectomy
RECRUITING · NA
-
Exercise, Brain Activity, and Weight Maintenance
RECRUITING · NA
-
RemI for Post-Bariatric Surgery Weight Regain
RECRUITING · NA
-
Postoperative VR for Recovery After Bariatric Surgery
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI